Cingulate Inc.

11/07/2024 | Press release | Distributed by Public on 11/07/2024 06:36

Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market